Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: a double-blind, randomized, placebo-controlled phase II study.
Suckfuell, Markus
Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: a double-blind, randomized, placebo-controlled phase II study. [electronic resource] - Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology Sep 2014 - 1317-26 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1537-4505
10.1097/MAO.0000000000000466 doi
Adolescent
Adult
Dose-Response Relationship, Drug
Double-Blind Method
Female
Hearing Loss, Sensorineural--drug therapy
Hearing Loss, Sudden--drug therapy
Humans
Male
Middle Aged
Neuroprotective Agents--administration & dosage
Peptides--administration & dosage
Prospective Studies
Tinnitus--drug therapy
Treatment Outcome
Tympanic Membrane--drug effects
Young Adult
Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: a double-blind, randomized, placebo-controlled phase II study. [electronic resource] - Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology Sep 2014 - 1317-26 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1537-4505
10.1097/MAO.0000000000000466 doi
Adolescent
Adult
Dose-Response Relationship, Drug
Double-Blind Method
Female
Hearing Loss, Sensorineural--drug therapy
Hearing Loss, Sudden--drug therapy
Humans
Male
Middle Aged
Neuroprotective Agents--administration & dosage
Peptides--administration & dosage
Prospective Studies
Tinnitus--drug therapy
Treatment Outcome
Tympanic Membrane--drug effects
Young Adult